MeSH term
Frequency | Condition_Probility | Adolescent | 8 | 0.0 |
Cell Differentiation | 5 | 0.0 |
Child | 11 | 0.0 |
Child, Preschool | 7 | 0.0 |
DNA-Binding Proteins/genetics/metabolism | 2 | 0.0 |
Female | 10 | 0.0 |
Gene Expression Profiling | 3 | 0.0 |
Humans | 64 | 0.0 |
Infant | 4 | 0.0 |
Male | 13 | 0.0 |
Metalloproteins/genetics/metabolism | 2 | 33.0 |
Polymerase Chain Reaction | 8 | 0.0 |
*Proto-Oncogene Proteins | 34 | 2.0 |
Research Support, Non-U.S. Gov't | 55 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 36 | 0.0 |
Survival Rate | 2 | 0.0 |
*Transcription Factors | 23 | 1.0 |
Tumor Markers, Biological | 3 | 0.0 |
Acute Disease | 2 | 0.0 |
Adult | 10 | 0.0 |
Base Sequence | 25 | 0.0 |
DNA Primers | 5 | 0.0 |
DNA-Binding Proteins/*metabolism | 8 | 0.0 |
Flow Cytometry | 3 | 0.0 |
Middle Aged | 3 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 4 | 0.0 |
Transcription Factors/*metabolism | 5 | 0.0 |
Chromosome Breakage | 2 | 2.0 |
Chromosomes, Human, Pair 1/genetics | 2 | 1.0 |
DNA-Binding Proteins/*genetics | 12 | 0.0 |
Gene Deletion | 6 | 0.0 |
Helix-Loop-Helix Motifs | 13 | 5.0 |
Karyotyping | 2 | 0.0 |
Leukemia, Lymphocytic, Acute/*genetics | 2 | 2.0 |
Leukemia, T-Cell, Acute/*genetics/immunology | 2 | 40.0 |
Oncogene Proteins, Fusion/genetics | 2 | 2.0 |
Reverse Transcriptase Polymerase Chain Reaction | 6 | 0.0 |
Sensitivity and Specificity | 4 | 0.0 |
Transcription Factors/genetics | 5 | 0.0 |
*Translocation, Genetic | 7 | 0.0 |
Animals | 28 | 0.0 |
Cell Line | 11 | 0.0 |
Cell Line, Transformed | 2 | 0.0 |
DNA-Binding Proteins/chemistry/*metabolism | 2 | 1.0 |
Mice | 22 | 0.0 |
Phosphorylation | 6 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 6 | 0.0 |
Signal Transduction | 3 | 0.0 |
Mice, Transgenic | 4 | 0.0 |
DNA-Binding Proteins/genetics | 3 | 0.0 |
Leukemia, T-Cell, Acute/genetics | 4 | 36.0 |
Models, Genetic | 3 | 0.0 |
Proto-Oncogene Proteins/*genetics | 4 | 0.0 |
Binding Sites | 8 | 0.0 |
DNA-Binding Proteins/*chemistry/*metabolism | 2 | 3.0 |
Hela Cells | 5 | 0.0 |
Leukemia, Erythroblastic, Acute | 3 | 3.0 |
Protein Biosynthesis | 3 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Transfection | 5 | 0.0 |
Tumor Cells, Cultured | 14 | 0.0 |
Sequence Deletion | 2 | 0.0 |
Cell Differentiation/genetics | 4 | 1.0 |
Gene Expression Regulation, Neoplastic | 5 | 0.0 |
3T3 Cells | 3 | 0.0 |
Cell Differentiation/drug effects | 2 | 0.0 |
DNA-Binding Proteins/chemistry/genetics/*metabolism | 2 | 1.0 |
Dimerization | 3 | 0.0 |
Promoter Regions (Genetics)/genetics | 2 | 0.0 |
Protein Binding | 6 | 0.0 |
*Trans-Activation (Genetics) | 4 | 0.0 |
Antigens, CD34/genetics | 2 | 22.0 |
Cell Culture Techniques/methods | 2 | 0.0 |
Cell Division | 2 | 0.0 |
Cells, Cultured | 4 | 0.0 |
Fetal Blood/cytology | 2 | 1.0 |
Gene Expression Regulation | 3 | 0.0 |
Infant, Newborn | 3 | 0.0 |
Molecular Sequence Data | 26 | 0.0 |
Proto-Oncogene Proteins/genetics | 2 | 0.0 |
RNA, Messenger/genetics | 3 | 0.0 |
Transcription, Genetic | 5 | 0.0 |
Cell Transformation, Neoplastic | 2 | 0.0 |
*Chromosomes, Human, Pair 1 | 3 | 0.0 |
Gene Rearrangement | 5 | 1.0 |
*Gene Deletion | 4 | 0.0 |
*Genes, Immunoglobulin | 2 | 1.0 |
Neoplasm, Residual | 2 | 2.0 |
Polymerase Chain Reaction/*methods | 2 | 0.0 |
Proto-Oncogenes | 2 | 1.0 |
Leukemia, T-Cell, Acute/*metabolism | 3 | 42.0 |
Bone Marrow/pathology | 2 | 0.0 |
Prognosis | 3 | 0.0 |
Survival Analysis | 2 | 0.0 |
Metalloproteins/*genetics | 2 | 8.0 |
*Oncogene Proteins | 3 | 4.0 |
Trans-Activation (Genetics)/genetics | 2 | 2.0 |
Helix-Loop-Helix Motifs/*physiology | 3 | 23.0 |
*Repressor Proteins | 3 | 0.0 |
Leukemia, T-Cell, Acute/*genetics | 10 | 25.0 |
Cell Nucleus/metabolism | 4 | 0.0 |
Cloning, Molecular | 6 | 0.0 |
Consensus Sequence | 7 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Hematopoiesis/genetics | 3 | 8.0 |
Immune Sera | 2 | 0.0 |
Mutation | 3 | 0.0 |
Transcription Factors/metabolism | 5 | 0.0 |
Blotting, Southern | 3 | 0.0 |
DNA-Binding Proteins/*genetics/metabolism | 3 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Transcription Factors/genetics/metabolism | 2 | 0.0 |
DNA Probes | 2 | 0.0 |
DNA, Neoplasm/genetics | 2 | 0.0 |
*Gene Rearrangement | 3 | 1.0 |
*Gene Rearrangement, T-Lymphocyte | 2 | 4.0 |
Leukemia, Lymphocytic, Acute, L1/*genetics | 2 | 5.0 |
Cell Division/genetics | 2 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 4 | 0.0 |
Etoposide/pharmacology | 2 | 1.0 |
*Gene Expression Regulation | 4 | 0.0 |
COS Cells | 3 | 0.0 |
*Erythropoiesis | 3 | 4.0 |
*Helix-Loop-Helix Motifs | 5 | 5.0 |
Amino Acid Sequence | 10 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Rats | 2 | 0.0 |
Genes, Reporter | 2 | 0.0 |
Metalloproteins/metabolism | 3 | 25.0 |
Nuclear Proteins/metabolism | 3 | 0.0 |
Regulatory Sequences, Nucleic Acid | 2 | 0.0 |
*Transcription, Genetic | 7 | 0.0 |
Chromosomes, Human, Pair 11 | 2 | 0.0 |
*Proto-Oncogenes | 2 | 0.0 |
Alleles | 2 | 0.0 |
*Enhancer Elements (Genetics) | 2 | 0.0 |
Globins/*genetics | 2 | 1.0 |
Sequence Alignment | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Oncogenes | 4 | 1.0 |
Phenotype | 2 | 0.0 |
Protein Conformation | 2 | 0.0 |
Translocation, Genetic | 5 | 0.0 |
Homeodomain Proteins/*metabolism | 2 | 1.0 |
Metalloproteins/*metabolism | 2 | 25.0 |
Chromosomes, Human, Pair 1 | 3 | 1.0 |
Comparative Study | 7 | 0.0 |
DNA/metabolism | 2 | 0.0 |
Leukemia, T-Cell, Acute/genetics/metabolism | 2 | 100.0 |
Restriction Mapping | 4 | 0.0 |
Mitogen-Activated Protein Kinase 3 | 2 | 0.0 |
*Mitogen-Activated Protein Kinases | 2 | 0.0 |
Proto-Oncogene Proteins/*genetics/metabolism | 2 | 1.0 |
DNA-Binding Proteins/biosynthesis/*metabolism | 2 | 3.0 |
Leukemia/*genetics | 2 | 1.0 |
Transcription Factors/*genetics/metabolism | 2 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
DNA Primers/chemistry | 2 | 0.0 |
DNA-Binding Proteins/genetics/*physiology | 2 | 0.0 |
Down-Regulation | 2 | 0.0 |
Immunophenotyping | 2 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
Gene Expression Profiling/*methods | 2 | 2.0 |
